Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Gut feeling measured: new device tracks digestive electrical activity

NCT ID NCT01697397

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tested a device that records the electrical signals naturally produced by the stomach, small intestine, and colon. Researchers compared readings from 88 people with and without irritable bowel syndrome (IBS) or other gut issues. The goal was to see if the device could reliably capture these signals, which might help understand digestive problems in the future.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

88 people

The number who actually took part.

Start date

Jul 2012

Finished

Jun 2015

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Irritable bowel syndrome, functional bowel disorder.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

General Eligibility Criteria: General Inclusion Criteria * Willing and able to provide informed consent; * Eighteen (18) years of age or older; * Willing and able to follow a specified study procedure regimen; * No known allergy to commercially available food or drink required by specified study procedure regimen; * Willing and able to recline and remain still during the recordings. General Exclusion Criteria * Subject has an implantable device such as a pacemaker, defibrillator, nerve stimulator, insulin pump, automatic analgesic pump, or other automated implanted medical device; * Known allergy to isopropyl (rubbing) alcohol; * Known allergy to Ag/AgCl electrodes; * Known allergy to glue adhesive (electrode adhesive); * Dietary restrictions not permitting intake of food or drink required by this protocol; * Dietary restrictions not permitting four (4) hour fasting period prior to start of myoelectric recording; * Subject is pregnant or suspects pregnancy; * Open sores or wounds on the abdomen; * Any injury in or around the area of electrode placement that would cause pain with gentle pressure required for electrode and lead wire placement; * Weight \> 300 lbs (136 Kg) (excess weight can interfere with quality of the signals). IBS With Complaints of GI Pain Eligibility Criteria IBS With Complaints of Pain Inclusion Criteria All answers must be "YES" to the All of the Following Inclusion Criteria Prior diagnosis of IBS and complaints of GI pain IBS With Complaints of Pain Exclusion Criteria All answers must be "NO" to the All of the Following Exclusion Criteria Functional dyspepsia; No reports of GI pain, past or present. Control Subjects Eligibility Criteria Subjects who do NOT have a prior diagnosis of functional GI disorder Control Subjects Inclusion Criteria All answers must be "YES" to the All of the Following Inclusion Criteria No prior diagnosis IBS; No complaints of GI pain. Control Subjects Exclusion Criteria All answers must be "NO" to the All of the Following Exclusion Criteria Current diagnosis of any GI disorder; Current or recent complaints of GI pain.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Gastrointestinal diseases are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • G-Tech Corporation

    Mountain View, California, 94040, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.